{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:48:47Z","timestamp":1794448127587,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI138212"],"award-info":[{"award-number":["P01 AI138212"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI177095"],"award-info":[{"award-number":["R01 AI177095"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74183-w","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:34:28Z","timestamp":1780979668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diverse germline-targeting HIV Env immunogens select for distinct mutations in the same knock-in mice B cell receptors"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-3197","authenticated-orcid":false,"given":"Parul","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Kallur Siddaramaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arineh","family":"Khechaduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey R.","family":"Salladay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-3178","authenticated-orcid":false,"given":"Karli","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Means","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna A.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9052-5428","authenticated-orcid":false,"given":"Luziana","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-5160","authenticated-orcid":false,"given":"Sabyasachi","family":"Baboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene K.","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5714-1545","authenticated-orcid":false,"given":"Derin","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-1672","authenticated-orcid":false,"suffix":"III","given":"John R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-5322","authenticated-orcid":false,"given":"James C.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-1271","authenticated-orcid":false,"given":"Frederick W.","family":"Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-6270","authenticated-orcid":false,"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-7097","authenticated-orcid":false,"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"74183_CR1","doi-asserted-by":"publisher","first-page":"eabp8155","DOI":"10.1126\/sciadv.abp8155","volume":"8","author":"CO Barnes","year":"2022","unstructured":"Barnes, C. O. et al. A naturally arising broad and potent CD4-binding site antibody with low somatic mutation. Sci. Adv. 8, eabp8155 (2022).","journal-title":"Sci. Adv."},{"key":"74183_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","volume":"45","author":"J Huang","year":"2016","unstructured":"Huang, J. et al. Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth. Immunity 45, 1108\u20131121 (2016).","journal-title":"Immunity"},{"key":"74183_CR3","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.cell.2018.03.061","volume":"173","author":"MM Sajadi","year":"2018","unstructured":"Sajadi, M. M. et al. Identification of near-pan-neutralizing antibodies against HIV-1 by deconvolution of plasma humoral responses. Cell 173, 1783\u20131795.e14 (2018).","journal-title":"Cell"},{"key":"74183_CR4","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","volume":"333","author":"JF Scheid","year":"2011","unstructured":"Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633\u20131637 (2011).","journal-title":"Science"},{"key":"74183_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1126\/science.1207532","volume":"333","author":"X Wu","year":"2011","unstructured":"Wu, X. et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593\u20131602 (2011).","journal-title":"Science"},{"key":"74183_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245\u2013258 (2013).","journal-title":"Immunity"},{"key":"74183_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N. Engl. J. Med 384, 1003\u20131014 (2021).","journal-title":"N. Engl. J. Med"},{"key":"74183_CR8","doi-asserted-by":"publisher","first-page":"E2083","DOI":"10.1073\/pnas.1208984109","volume":"109","author":"AP West Jr","year":"2012","unstructured":"West, A. P. Jr et al. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. USA 109, E2083\u2013E2090 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74183_CR9","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1073\/pnas.1303682110","volume":"110","author":"L Scharf","year":"2013","unstructured":"Scharf, L. et al. Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody. Proc. Natl. Acad. Sci. USA 110, 6049\u20136054 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74183_CR10","doi-asserted-by":"crossref","unstructured":"Scharf, L. et al., Structural basis for germline antibody recognition of HIV-1 immunogens. Elife. 5 (2016).","DOI":"10.7554\/eLife.13783"},{"key":"74183_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1126\/science.1213782","volume":"334","author":"R Diskin","year":"2011","unstructured":"Diskin, R. et al. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334, 1289\u20131293 (2011).","journal-title":"Science"},{"key":"74183_CR12","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.celrep.2016.10.017","volume":"17","author":"C Yacoob","year":"2016","unstructured":"Yacoob, C. et al. Differences in allelic frequency and CDRH3 region limit the engagement of HIV Env immunogens by putative VRC01 neutralizing antibody precursors. Cell Rep. 17, 1560\u20131570 (2016).","journal-title":"Cell Rep."},{"key":"74183_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.immuni.2018.10.015","volume":"49","author":"M Bonsignori","year":"2018","unstructured":"Bonsignori, M. et al. Inference of the HIV-1 VRC01 antibody lineage unmutated common ancestor reveals alternative pathways to overcome a key glycan barrier. Immunity 49, 1162\u20131174.e8 (2018).","journal-title":"Immunity"},{"key":"74183_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine, J. et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711\u2013716 (2013).","journal-title":"Science"},{"key":"74183_CR15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1259206","volume":"346","author":"AT McGuire","year":"2014","unstructured":"McGuire, A. T. et al. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies. Science 346, 1380\u20131383 (2014).","journal-title":"Science"},{"key":"74183_CR16","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1128\/JVI.03228-13","volume":"88","author":"AT McGuire","year":"2014","unstructured":"McGuire, A. T. et al. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D. J. Virol. 88, 2645\u20132657 (2014).","journal-title":"J. Virol."},{"key":"74183_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10618","volume":"7","author":"AT McGuire","year":"2016","unstructured":"McGuire, A. T. et al. Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. Nat. Commun. 7, 10618 (2016).","journal-title":"Nat. Commun."},{"key":"74183_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.20122824","volume":"210","author":"AT McGuire","year":"2013","unstructured":"McGuire, A. T. et al. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J. Exp. Med. 210, 655\u2013663 (2013).","journal-title":"J. Exp. Med."},{"key":"74183_CR19","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1084\/jem.20161160","volume":"214","author":"M Medina-Ramirez","year":"2017","unstructured":"Medina-Ramirez, M. et al. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J. Exp. Med. 214, 2573\u20132590 (2017).","journal-title":"J. Exp. Med."},{"key":"74183_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/imr.12483","volume":"275","author":"L Stamatatos","year":"2017","unstructured":"Stamatatos, L., Pancera, M. & McGuire, A. T. Germline-targeting immunogens. Immunol. Rev. 275, 203\u2013216 (2017).","journal-title":"Immunol. Rev."},{"key":"74183_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.celrep.2017.04.013","volume":"19","author":"T Zhou","year":"2017","unstructured":"Zhou, T. et al. Quantification of the impact of the HIV-1-Glycan shield on antibody elicitation. Cell Rep. 19, 719\u2013732 (2017).","journal-title":"Cell Rep."},{"key":"74183_CR22","doi-asserted-by":"crossref","unstructured":"Borst, A. J. et al. Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core. Elife 7 (2018).","DOI":"10.7554\/eLife.37688"},{"key":"74183_CR23","doi-asserted-by":"publisher","first-page":"e1004932","DOI":"10.1371\/journal.ppat.1004932","volume":"11","author":"ET Crooks","year":"2015","unstructured":"Crooks, E. T. et al. Vaccine-elicited Tier 2 HIV-1 neutralizing antibodies bind to quaternary epitopes involving glycan-deficient patches proximal to the CD4 binding site. PLoS Pathog. 11, e1004932 (2015).","journal-title":"PLoS Pathog."},{"key":"74183_CR24","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1126\/science.1070441","volume":"296","author":"B Gaschen","year":"2002","unstructured":"Gaschen, B. et al. Diversity considerations in HIV-1 vaccine selection. Science 296, 2354\u20132360 (2002).","journal-title":"Science"},{"key":"74183_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/088922202753747914","volume":"18","author":"EM Long","year":"2002","unstructured":"Long, E. M. et al. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. AIDS Res Hum. Retroviruses 18, 567\u2013576 (2002).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"74183_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","volume":"11","author":"GE Gray","year":"2011","unstructured":"Gray, G. E. et al. Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11, 507\u2013515 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"74183_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virol.2011.11.023","volume":"423","author":"X Huang","year":"2012","unstructured":"Huang, X. et al. Highly conserved HIV-1 gp120 glycans proximal to the CD4-binding region affect viral infectivity and neutralizing antibody induction. Virology 423, 97\u2013106 (2012).","journal-title":"Virology"},{"key":"74183_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1128\/JVI.01691-07","volume":"82","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J. Virol. 82, 638\u2013651 (2008).","journal-title":"J. Virol."},{"key":"74183_CR29","doi-asserted-by":"publisher","first-page":"105473","DOI":"10.1016\/j.isci.2022.105473","volume":"25","author":"ML Knudsen","year":"2022","unstructured":"Knudsen, M. L. et al. Adjuvants influence the maturation of VRC01-like antibodies during immunization. iScience 25, 105473 (2022).","journal-title":"iScience"},{"key":"74183_CR30","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/j.celrep.2019.10.071","volume":"29","author":"KR Parks","year":"2019","unstructured":"Parks, K. R. et al. Overcoming steric restrictions of VRC01 HIV-1 neutralizing antibodies through immunization. Cell Rep. 29, 3060\u20133072.e7 (2019).","journal-title":"Cell Rep."},{"key":"74183_CR31","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1128\/JVI.74.15.6769-6776.2000","volume":"74","author":"A Ly","year":"2000","unstructured":"Ly, A. & Stamatatos, L. V2 loop Glycosylation of the human Immunodeficiency Virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J. Virol. 74, 6769\u20136776 (2000).","journal-title":"J. Virol."},{"key":"74183_CR32","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1128\/JVI.79.14.9069-9080.2005","volume":"79","author":"CJ Saunders","year":"2005","unstructured":"Saunders, C. J. et al. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 79, 9069\u20139080 (2005).","journal-title":"J. Virol."},{"key":"74183_CR33","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1128\/jvi.67.8.4557-4565.1993","volume":"67","author":"R Wyatt","year":"1993","unstructured":"Wyatt, R. et al. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67, 4557\u20134565 (1993).","journal-title":"J. Virol."},{"key":"74183_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14670-w","volume":"11","author":"T Bradley","year":"2020","unstructured":"Bradley, T. et al. Immune checkpoint modulation enhances HIV-1 antibody induction. Nat. Commun. 11, 948 (2020).","journal-title":"Nat. Commun."},{"key":"74183_CR35","doi-asserted-by":"publisher","first-page":"eadn0223","DOI":"10.1126\/scitranslmed.adn0223","volume":"16","author":"CA Cottrell","year":"2024","unstructured":"Cottrell, C. A. et al. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. Sci. Transl. Med. 16, eadn0223 (2024).","journal-title":"Sci. Transl. Med."},{"key":"74183_CR36","doi-asserted-by":"publisher","first-page":"eadd6502","DOI":"10.1126\/science.add6502","volume":"378","author":"DJ Leggat","year":"2022","unstructured":"Leggat, D. J. et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378, eadd6502 (2022).","journal-title":"Science"},{"key":"74183_CR37","doi-asserted-by":"publisher","first-page":"eadn0622","DOI":"10.1126\/sciimmunol.adn0622","volume":"9","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models. Sci. Immunol. 9, eadn0622 (2024).","journal-title":"Sci. Immunol."},{"key":"74183_CR38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2020.09.007","volume":"53","author":"YR Lin","year":"2020","unstructured":"Lin, Y. R. et al. HIV-1 VRC01 germline-targeting immunogens select distinct epitope-specific B cell receptors. Immunity 53, 840\u2013851.e6 (2020).","journal-title":"Immunity"},{"key":"74183_CR39","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","volume":"351","author":"JG Jardine","year":"2016","unstructured":"Jardine, J. G. et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science 351, 1458\u20131463 (2016).","journal-title":"Science"},{"key":"74183_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.aac5894","volume":"349","author":"JG Jardine","year":"2015","unstructured":"Jardine, J. G. et al. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349, 156\u2013161 (2015).","journal-title":"Science"},{"key":"74183_CR41","unstructured":"Caniels, T. G. et al. Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science, p. eadv5572 (2025)."},{"key":"74183_CR42","unstructured":"Willis, J. R. et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science, p. eadr8382 (2025)."},{"key":"74183_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00744-24","volume":"98","author":"P Agrawal","year":"2024","unstructured":"Agrawal, P. et al. Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env. J. Virol. 98, e0074424 (2024).","journal-title":"J. Virol."},{"key":"74183_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41\u201360 (2005).","journal-title":"J. Struct. Biol."},{"key":"74183_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A. et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"74183_CR46","doi-asserted-by":"publisher","first-page":"eabm3948","DOI":"10.1126\/sciadv.abm3948","volume":"8","author":"MD Gray","year":"2022","unstructured":"Gray, M. D. et al. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. Sci. Adv. 8, eabm3948 (2022).","journal-title":"Sci. Adv."},{"key":"74183_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"74183_CR48","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/s41592-024-02464-7","volume":"21","author":"CM Ives","year":"2024","unstructured":"Ives, C. M. et al. Restoring protein glycosylation with GlycoShape. Nat. Methods 21, 2117\u20132127 (2024).","journal-title":"Nat. Methods"},{"key":"74183_CR49","doi-asserted-by":"publisher","first-page":"11361","DOI":"10.1021\/acs.analchem.5b02721","volume":"87","author":"L He","year":"2015","unstructured":"He, L. et al. Extracting accurate precursor information for tandem mass spectra by RawConverter. Anal. Chem. 87, 11361\u201311367 (2015).","journal-title":"Anal. Chem."},{"key":"74183_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jprot.2015.07.001","volume":"129","author":"T Xu","year":"2015","unstructured":"Xu, T. et al. ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity. J. Proteom. 129, 16\u201324 (2015).","journal-title":"J. Proteom."},{"key":"74183_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/pr015504q","volume":"1","author":"DL Tabb","year":"2002","unstructured":"Tabb, D. L., McDonald, W. H. & Yates, J. R. 3rd DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21\u201326 (2002).","journal-title":"J. Proteome Res."},{"key":"74183_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/pr025556v","volume":"2","author":"J Peng","year":"2003","unstructured":"Peng, J. et al. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC-MS\/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2, 43\u201350 (2003).","journal-title":"J. Proteome Res."},{"key":"74183_CR53","doi-asserted-by":"publisher","first-page":"13651","DOI":"10.1021\/acs.analchem.1c03059","volume":"93","author":"S Baboo","year":"2021","unstructured":"Baboo, S. et al. DeGlyPHER: An Ultrasensitive method for the analysis of viral spike N-Glycoforms. Anal. Chem. 93, 13651\u201313657 (2021).","journal-title":"Anal. Chem."},{"key":"74183_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.mie.2022.09.004","volume":"682","author":"S Baboo","year":"2023","unstructured":"Baboo, S. et al. DeGlyPHER: Highly sensitive site-specific analysis of N-linked glycans on proteins. Methods Enzymol. 682, 137\u2013185 (2023).","journal-title":"Methods Enzymol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74183-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:02:20Z","timestamp":1785110540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74183-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74183"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74183-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7320"}}